LiquidiaLQDA +1.64%67 FCF Yield % is 0.56 as of Jun. 27, 2026. GuruFocus rates LQDA with a GF Score™ of 67/100 and a GF Value™ of $218.97 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Liquidia ranks worse than 50.55% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Liquidia FCF Yield % Related Terms
Liquidia FCF Yield % Historical Data
* Premium members only.
The historical data trend for Liquidia's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Liquidia's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liquidia FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Liquidia's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Liquidia's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liquidia (LQDA) has a FCF Yield % of 0.56 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Liquidia and its competitors. According to the industry distribution chart, Liquidia ranks #508 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 50.5%.
Is Liquidia's FCF Yield % too high?
Liquidia's current FCF Yield % is 0.56. The Drug Manufacturers industry median FCF Yield % is 0.67. Liquidia's value of 0.56 is 16.4% below this industry median. Based on the distribution chart, Liquidia ranks #508 out of 1005 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Liquidia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Liquidia's FCF Yield % compare to HIMS and LNTH?
According to the Drug Manufacturers industry distribution chart, Liquidia ranks #508 out of 1005 companies for FCF Yield %. This places Liquidia in the lower half of its industry. The industry median FCF Yield % is 0.67. Liquidia's value of 0.56 is 16.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Liquidia's current FCF Yield % of 0.56 is 16.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Liquidia and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liquidia's current FCF Yield % is 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liquidia stock overvalued right now?
Based on GuruFocus' analysis, Liquidia (LQDA) is currently considered Possible Value Trap. The stock's GF Value™ is $218.97, compared to a current price of $78.17 — trading 64.3% below its estimated fair value. The current FCF Yield % is 0.56 and 16.4% below the Drug Manufacturers industry median of 0.67. Liquidia's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Liquidia (LQDA), the current FCF Yield % is 0.56 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liquidia (LQDA) Overvalued in 2026?
Based on GuruFocus' analysis, Liquidia stock appears to be undervalued.
The current stock price of $78.17 is trading 64.3% below its estimated GF Value™ of $218.97.
GuruFocus considers Liquidia to be Possible Value Trap.
Key valuation signals for LQDA:
FCF Yield %: 0.56
GF Value™: $218.97 vs. price of $78.17 (64.3% below fair value)
Industry Position: 16.4% below the Drug Manufacturers median (#508 of 1005)
No single metric tells the full story. See the LQDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
67GF Score
Get the complete analysis for LQDA
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LQDA has been successfully added to your 
